RDY logo

RDY EBITDA

annual EBITDA:

$1.02B+$73.08M(+7.69%)
March 31, 2025

Summary

  • As of today (September 17, 2025), RDY annual EBITDA is $1.02 billion, with the most recent change of +$73.08 million (+7.69%) on March 31, 2025.
  • During the last 3 years, RDY annual EBITDA has risen by +$402.31 million (+64.73%).
  • RDY annual EBITDA is now at all-time high.

Performance

RDY EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRDYincome statement metrics

quarterly EBITDA:

$252.46M+$15.75M(+6.65%)
June 30, 2025

Summary

  • As of today (September 17, 2025), RDY quarterly EBITDA is $252.46 million, with the most recent change of +$15.75 million (+6.65%) on June 30, 2025.
  • Over the past year, RDY quarterly EBITDA has dropped by -$3.50 million (-1.37%).
  • RDY quarterly EBITDA is now -1.84% below its all-time high of $257.18 million, reached on September 30, 2024.

Performance

RDY quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRDYincome statement metrics

TTM EBITDA:

$746.35M-$3.50M(-0.47%)
June 30, 2025

Summary

  • As of today (September 17, 2025), RDY TTM EBITDA is $746.35 million, with the most recent change of -$3.50 million (-0.47%) on June 30, 2025.
  • Over the past year, RDY TTM EBITDA has dropped by -$189.37 million (-20.24%).
  • RDY TTM EBITDA is now -23.16% below its all-time high of $971.34 million, reached on September 30, 2024.

Performance

RDY TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRDYincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

RDY EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+7.7%-1.4%-20.2%
3 y3 years+64.7%+109.3%+20.9%
5 y5 years+76.6%+71.8%+20.2%

RDY EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+64.7%-1.8%+109.3%-23.2%+20.9%
5 y5-yearat high+76.6%-1.8%+109.3%-23.2%+28.9%
alltimeall timeat high+8595.2%-1.8%>+9999.0%-23.2%+4610.7%

RDY EBITDA History

DateAnnualQuarterlyTTM
Jun 2025
-
$252.46M(+6.7%)
$746.35M(-0.5%)
Mar 2025
$1.02B(+7.7%)
$236.71M(-8.0%)
$749.85M(-22.8%)
Sep 2024
-
$257.18M(+0.5%)
$971.34M(+3.8%)
Jun 2024
-
$255.96M(+19.1%)
$935.72M(+0.7%)
Mar 2024
$950.72M(+17.8%)
$214.87M(-11.7%)
$929.30M(+2.5%)
Dec 2023
-
$243.34M(+9.8%)
$906.89M(-0.9%)
Sep 2023
-
$221.55M(-11.2%)
$914.69M(-1.7%)
Jun 2023
-
$249.55M(+29.7%)
$930.50M(+16.1%)
Mar 2023
$806.96M(+29.8%)
$192.46M(-23.4%)
$801.56M(+4.8%)
Dec 2022
-
$251.13M(+5.8%)
$764.63M(+13.4%)
Sep 2022
-
$237.37M(+96.8%)
$674.49M(+9.2%)
Jun 2022
-
$120.61M(-22.5%)
$617.40M(-0.4%)
Mar 2022
$621.49M(+2.9%)
$155.53M(-3.4%)
$619.81M(+2.9%)
Dec 2021
-
$160.99M(-10.7%)
$602.56M(+1.3%)
Sep 2021
-
$180.28M(+46.6%)
$594.76M(+2.7%)
Jun 2021
-
$123.01M(-11.0%)
$579.16M(-4.0%)
Mar 2021
$603.81M(+4.1%)
$138.28M(-9.7%)
$603.12M(+1.4%)
Dec 2020
-
$153.18M(-7.0%)
$594.65M(+1.6%)
Sep 2020
-
$164.68M(+12.0%)
$585.00M(-5.8%)
Jun 2020
-
$146.97M(+13.2%)
$620.71M(+7.2%)
Mar 2020
$579.77M(+27.6%)
$129.81M(-9.6%)
$578.90M(+2.4%)
Dec 2019
-
$143.53M(-28.4%)
$565.36M(+5.6%)
Sep 2019
-
$200.39M(+90.6%)
$535.54M(+21.3%)
Jun 2019
-
$105.16M(-9.6%)
$441.51M(-1.9%)
Mar 2019
$454.29M(+27.9%)
$116.28M(+2.3%)
$449.98M(+7.3%)
Dec 2018
-
$113.71M(+6.9%)
$419.32M(-1.4%)
Sep 2018
-
$106.36M(-6.4%)
$425.39M(+0.8%)
Jun 2018
-
$113.63M(+32.7%)
$421.94M(+18.6%)
Mar 2018
$355.10M(-1.4%)
$85.62M(-28.5%)
$355.74M(+1.0%)
Dec 2017
-
$119.78M(+16.4%)
$352.08M(-1.6%)
Sep 2017
-
$102.91M(+117.0%)
$357.73M(+4.0%)
Jun 2017
-
$47.43M(-42.1%)
$343.93M(-2.5%)
Mar 2017
$360.22M(-39.6%)
$81.95M(-34.7%)
$352.79M(-8.7%)
Dec 2016
-
$125.44M(+40.8%)
$386.32M(-6.5%)
Sep 2016
-
$89.10M(+58.3%)
$413.01M(-17.1%)
Jun 2016
-
$56.29M(-51.3%)
$498.28M(-16.6%)
Mar 2016
$596.54M(+7.3%)
$115.48M(-24.1%)
$597.28M(-2.7%)
Dec 2015
-
$152.14M(-12.7%)
$613.97M(-0.0%)
Sep 2015
-
$174.37M(+12.3%)
$614.15M(+7.1%)
Jun 2015
-
$155.30M(+17.5%)
$573.55M(+3.4%)
Mar 2015
$555.71M(+7.9%)
$132.17M(-13.2%)
$554.71M(+1.6%)
Dec 2014
-
$152.32M(+13.9%)
$546.04M(-1.0%)
Sep 2014
-
$133.77M(-2.0%)
$551.43M(+0.4%)
Jun 2014
-
$136.45M(+10.5%)
$549.14M(+7.9%)
Mar 2014
$514.90M(+11.9%)
$123.50M(-21.7%)
$508.84M(-2.1%)
Dec 2013
-
$157.71M(+19.9%)
$519.98M(+11.2%)
Sep 2013
-
$131.48M(+36.7%)
$467.72M(+1.3%)
Jun 2013
-
$96.15M(-28.6%)
$461.94M(+1.0%)
Mar 2013
$459.95M
$134.64M(+27.7%)
$457.27M(+1.3%)
Dec 2012
-
$105.45M(-16.1%)
$451.56M(-12.4%)
Sep 2012
-
$125.69M(+37.4%)
$515.62M(+4.5%)
DateAnnualQuarterlyTTM
Jun 2012
-
$91.49M(-29.0%)
$493.52M(+1.1%)
Mar 2012
$495.93M(+44.1%)
$128.94M(-23.9%)
$487.96M(+7.0%)
Dec 2011
-
$169.51M(+63.6%)
$456.03M(+22.9%)
Sep 2011
-
$103.58M(+20.5%)
$371.00M(+4.4%)
Jun 2011
-
$85.93M(-11.4%)
$355.38M(+3.3%)
Mar 2011
$344.09M(+12.9%)
$97.01M(+14.8%)
$344.17M(+10.7%)
Dec 2010
-
$84.47M(-4.0%)
$310.79M(+1.8%)
Sep 2010
-
$87.96M(+17.7%)
$305.22M(+6.8%)
Jun 2010
-
$74.72M(+17.4%)
$285.86M(-5.0%)
Mar 2010
$304.89M(-3.2%)
$63.63M(-19.4%)
$300.99M(-18.1%)
Dec 2009
-
$78.91M(+15.0%)
$367.67M(+3.1%)
Sep 2009
-
$68.61M(-23.6%)
$356.48M(+5.0%)
Jun 2009
-
$89.85M(-31.0%)
$339.52M(+14.8%)
Mar 2009
$315.07M(+53.4%)
$130.31M(+92.4%)
$295.79M(+46.1%)
Dec 2008
-
$67.72M(+31.1%)
$202.51M(+12.6%)
Sep 2008
-
$51.64M(+12.0%)
$179.77M(+2.9%)
Jun 2008
-
$46.12M(+24.6%)
$174.65M(-7.8%)
Mar 2008
$205.39M(-44.0%)
$37.02M(-17.7%)
$189.38M(-33.4%)
Dec 2007
-
$44.98M(-3.3%)
$284.24M(-6.5%)
Sep 2007
-
$46.52M(-23.5%)
$303.93M(-15.1%)
Jun 2007
-
$60.85M(-53.9%)
$358.16M(+2.5%)
Mar 2007
$366.87M(+405.9%)
$131.88M(+103.9%)
$349.38M(+47.9%)
Dec 2006
-
$64.67M(-35.8%)
$236.26M(+27.1%)
Sep 2006
-
$100.76M(+93.5%)
$185.95M(+42.1%)
Jun 2006
-
$52.07M(+177.6%)
$130.82M(+32.1%)
Mar 2006
$72.52M(+118.9%)
$18.76M(+30.6%)
$99.03M(+14.6%)
Dec 2005
-
$14.36M(-68.5%)
$86.38M(+16.4%)
Sep 2005
-
$45.63M(+125.0%)
$74.22M(+100.9%)
Jun 2005
-
$20.28M(+232.0%)
$36.95M(+8.4%)
Mar 2005
$33.13M(-49.6%)
$6.11M(+177.8%)
$34.10M(+15.8%)
Dec 2004
-
$2.20M(-73.7%)
$29.45M(-31.7%)
Sep 2004
-
$8.36M(-52.0%)
$43.11M(-27.5%)
Jun 2004
-
$17.42M(+1090.2%)
$59.45M(-9.4%)
Mar 2004
$65.70M(-28.9%)
$1.46M(-90.8%)
$65.65M(-20.1%)
Dec 2003
-
$15.86M(-35.8%)
$82.13M(-2.5%)
Sep 2003
-
$24.70M(+4.5%)
$84.25M(+1.7%)
Jun 2003
-
$23.63M(+31.7%)
$82.83M(-8.7%)
Mar 2003
$92.35M(-26.2%)
$17.94M(-0.3%)
$90.75M(-5.0%)
Dec 2002
-
$17.99M(-22.7%)
$95.51M(-15.6%)
Sep 2002
-
$23.27M(-26.2%)
$113.11M(-20.0%)
Jun 2002
-
$31.55M(+39.0%)
$141.44M(+12.5%)
Mar 2002
$125.17M(+128.3%)
$22.70M(-36.2%)
$125.73M(+22.0%)
Dec 2001
-
$35.59M(-31.0%)
$103.03M(+52.8%)
Sep 2001
-
$51.60M(+225.7%)
$67.44M(+325.7%)
Jun 2001
-
$15.84M
$15.84M
Mar 2001
$54.83M(+129.1%)
-
-
Mar 2000
$23.93M(+30.3%)
-
-
Mar 1999
$18.37M(-8.7%)
-
-
Mar 1998
$20.13M(+71.0%)
-
-
Mar 1997
$11.77M(-13.1%)
-
-
Mar 1996
$13.55M(+3.4%)
-
-
Mar 1995
$13.11M
-
-

FAQ

  • What is Dr. Reddy's Laboratories Limited annual EBITDA?
  • What is the all time high annual EBITDA for Dr. Reddy's Laboratories Limited?
  • What is Dr. Reddy's Laboratories Limited annual EBITDA year-on-year change?
  • What is Dr. Reddy's Laboratories Limited quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Dr. Reddy's Laboratories Limited?
  • What is Dr. Reddy's Laboratories Limited quarterly EBITDA year-on-year change?
  • What is Dr. Reddy's Laboratories Limited TTM EBITDA?
  • What is the all time high TTM EBITDA for Dr. Reddy's Laboratories Limited?
  • What is Dr. Reddy's Laboratories Limited TTM EBITDA year-on-year change?

What is Dr. Reddy's Laboratories Limited annual EBITDA?

The current annual EBITDA of RDY is $1.02B

What is the all time high annual EBITDA for Dr. Reddy's Laboratories Limited?

Dr. Reddy's Laboratories Limited all-time high annual EBITDA is $1.02B

What is Dr. Reddy's Laboratories Limited annual EBITDA year-on-year change?

Over the past year, RDY annual EBITDA has changed by +$73.08M (+7.69%)

What is Dr. Reddy's Laboratories Limited quarterly EBITDA?

The current quarterly EBITDA of RDY is $252.46M

What is the all time high quarterly EBITDA for Dr. Reddy's Laboratories Limited?

Dr. Reddy's Laboratories Limited all-time high quarterly EBITDA is $257.18M

What is Dr. Reddy's Laboratories Limited quarterly EBITDA year-on-year change?

Over the past year, RDY quarterly EBITDA has changed by -$3.50M (-1.37%)

What is Dr. Reddy's Laboratories Limited TTM EBITDA?

The current TTM EBITDA of RDY is $746.35M

What is the all time high TTM EBITDA for Dr. Reddy's Laboratories Limited?

Dr. Reddy's Laboratories Limited all-time high TTM EBITDA is $971.34M

What is Dr. Reddy's Laboratories Limited TTM EBITDA year-on-year change?

Over the past year, RDY TTM EBITDA has changed by -$189.37M (-20.24%)
On this page